SIMARJEET MANOCHA: Open Payments
NPI 1548725666 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,091 in 84 payments from 24 companies in 2025. Trend: 2023 $2,339 · 2024 $1,524 · 2025 $2,091
Food & beverage: $2,091
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $336 |
| Otsuka America Pharmaceutical, Inc. | 13 | $256 |
| Dexcom, Inc. | 8 | $252 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Lilly USA, LLC | 5 | $133 |
| Radius Health, Inc. | 5 | $133 |
| GlaxoSmithKline, LLC. | 5 | $105 |
| HARMONY BIOSCIENCES LLC | 2 | $98 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| PFIZER INC. | 3 | $67 |
Products named: REXULTI, Dexcom G6 Transmitter, Wegovy, REZDIFFRA, MOUNJARO, TRELEGY ELLIPTA, WAKIX, Ozempic.
Industry payments across CA — which companies pay providers there.
